MFN2 and amyotrophic lateral sclerosis: Along the same lines, forced expression of Mfn2 in the spinal cord in the ALS-modeling Sod1G93A transgenic mice rescued NMJ loss and muscular atrophy and delayed overt disease onset by 60 days, while mitochondria were still fragmented.